Catheter Precision, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
AMEX
10-K: Catheter Precision Faces Going Concern Doubt Amid Losses, Pursues New Capital & Aviation Venture
Catheter Precision, a medical device company, reported recurring losses and substantial doubt about its ability to continue as a going concern, while actively raising capital and diversifying into private aviation.
AMEX
Catheter Precision files an amendment to its 2024 annual report to include previously omitted information regarding related party transactions.
AMEX
Catheter Precision's 2024 10-K filing highlights continued losses, a need for additional capital, and ongoing efforts to commercialize its VIVO and LockeT products.
AMEX
Catheter Precision's 10-K filing details its capital stock, including common and preferred shares, warrants, and anti-takeover provisions.